Changes after publication
May 2014: minor maintenance
February 2014: implementation section updated to clarify that dronedarone is recommended as an option for treating non-permanent atrial fibrillation. Additional minor maintenance update also carried out.
December 2012: recommendation 1.1 amended to reflect the change in the dronedarone marketing authorisation.
October 2012: a note has been added explaining the review decision for this guidance and the change in the dronedarone marketing authorisation.
March 2012: minor maintenance